M Perraki
Overview
Explore the profile of M Perraki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milaki G, Messaritakis I, Koinis F, Kotsakis A, Apostolaki S, Dermitzaki E, et al.
Cancer Chemother Pharmacol
. 2017 May;
80(1):101-108.
PMID: 28523597
Background: The detection of circulating tumor cells (CTCs) is of prognostic significance in several tumor types. The present study evaluated the detection and the clinical relevance of CK19mRNA(+) CTCs in...
2.
Georgoulias V, Apostolaki S, Bozionelou V, Politaki E, Perraki M, Georgoulia N, et al.
Cancer Chemother Pharmacol
. 2014 Oct;
74(6):1217-25.
PMID: 25344760
Purpose: To evaluate the effect of front-line chemotherapy on CK-19mRNA+ circulating tumor cells (CTCs) and their relevance in patients with metastatic breast cancer (MBC). Patients And Methods: The presence of...
3.
Xenidis N, Perraki M, Apostolaki S, Agelaki S, Kalbakis K, Vardakis N, et al.
Br J Cancer
. 2013 Jan;
108(3):549-56.
PMID: 23329233
Background: To determine the effect of adjuvant taxane-free and taxane-based chemotherapy regimens on the elimination of circulating tumour cells (CTCs) in patients with early breast cancer. Methods: The presence of...
4.
Androulakis N, Agelaki S, Perraki M, Apostolaki S, Bozionelou V, Pallis A, et al.
Br J Cancer
. 2012 Jun;
106(12):1917-25.
PMID: 22669159
Background: To investigate the clinical relevance of CK-19mRNA-positive circulating tumour cells (CTCs) detected before the initiation of front-line treatment in patients with metastatic breast cancer (MBC). Methods: The presence of...
5.
Georgoulias V, Bozionelou V, Agelaki S, Perraki M, Apostolaki S, Kallergi G, et al.
Ann Oncol
. 2012 Mar;
23(7):1744-50.
PMID: 22377561
Background: Since the detection of circulating tumor cells (CTCs) which express HER2 is an adverse prognostic factor in early breast cancer patients, we investigated the effect of trastuzumab on patients'...
6.
Tsakiridis P, Oustadakis P, Katsiapi A, Perraki M, Agatzini-Leonardou S
J Hazard Mater
. 2011 Aug;
194:42-7.
PMID: 21868153
The research work presented in this paper is focused on the development of a purification process of red mud sulphate leach liquor for the recovery of titanium oxide (TiO(2)) nano-powders...
7.
Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, et al.
Br J Cancer
. 2009 Jul;
101(4):589-97.
PMID: 19623181
Background: To compare detection rates and evaluate the clinical relevance of cytokeratin-19 (CK-19) mRNA-positive cells in the peripheral blood (circulating tumour cells, CTCs) and bone marrow (disseminated tumour cells; DTCs)...
8.
Xenidis N, Markos V, Apostolaki S, Perraki M, Pallis A, Sfakiotaki G, et al.
Ann Oncol
. 2007 May;
18(10):1623-31.
PMID: 17515404
Background: The purpose of this study was to evaluate the effect of adjuvant treatment with tamoxifen on the CK-19 mRNA+ cells in patients with early-stage breast cancer. Patients And Methods:...
9.
Apostolaki S, Perraki M, Pallis A, Bozionelou V, Agelaki S, Kanellou P, et al.
Ann Oncol
. 2007 Feb;
18(5):851-8.
PMID: 17301075
Background: The purpose of this study was to evaluate the prognostic value of circulating tumor cells (CTCs) expressing HER2 messenger RNA (mRNA) after the administration of adjuvant chemotherapy in women...
10.
Stathopoulos E, Sanidas E, Kafousi M, Mavroudis D, Askoxylakis J, Bozionelou V, et al.
Ann Oncol
. 2005 Jan;
16(2):240-6.
PMID: 15668277
Background: To investigate the incidence of direct hematogenous spread of cancer cells in patients with early-stage breast cancer by studying the presence of occult tumor cytokeratin-19 (CK-19) mRNA(+) cells in...